Trending...
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Juneau's 14-day COVID-19 recap: Dec. 28 – Jan. 10
- Morningstar names Quantified STF Fund top-performing tactical-allocation fund in 2020
Study Finds Increase in Protein Nutritional Supplements Does Not Improve Mortality Rates for Hemodialysis Patients with Normal Nutritional Status
NASHVILLE, Tenn. - AkGlobe -- Dialysis Clinic, Inc. (DCI) completed a three-year pragmatic trial of over 10,000 hemodialysis patients and concluded that adding an intensive oral protein nutritional supplement protocol does not improve mortality rates compared to patients receiving standard care.
"It is an accomplishment for the many patients who joined the study and for the clinical staff at DCI units to have undertaken a trial of this size and this scope and answered an important question. While it is disappointing that oral protein supplements, items like protein bars that you can buy at any store, did not lower mortality in hemodialysis patients with good nutritional status, it is important to say that this result does not tell us anything about giving protein supplements to people with low serum albumin. We do have observational data that suggest protein supplements have benefits in dialysis patients with low albumin," said Daniel Weiner, MD, of Tufts Medical Center in Boston and Medical Director of Clinical Research for DCI.
More on AkGlobe News
The cluster randomized pragmatic study, named The HELPS-HD Trial, enrolled 10,457 patients from 105 DCI participating facilities. Patients were randomized to either the standard protocol group, whereby only those patients with an albumin level below 3.5 g/dL received supplement, or the intensive protocol group, where supplements were given to patients regardless of their albumin levels. The most common supplements used were protein bars, and all supplements had approximately 15g to 20g of protein. Mean follow-up was 21.2 months.
"We tried to keep this as real-world and pragmatic as possible," Weiner said.
At the conclusion of the study, there were 3,628 deaths, with 35.8% from the intensive group and 36.5% from the standard group. There was no significant difference in the death rate between the groups, even after adjusting for age, sex, race, and incident patient status.
"To be able to verbally consent over 10,000 patients in a randomized clinical trial is a testament to the dedication of the DCI staff to our patients and to our mission as a company. I am very proud to work for DCI and this incredible team in our quest to find the best possible care for our patients," said Karen Majchrzak, Director of Clinical Research at DCI.
More on AkGlobe News
About DCI
Founded in 1971, Dialysis Clinic, Inc. (DCI) is the nation's largest non-profit dialysis provider with over 250 dialysis clinics in 30 states. Headquartered in Nashville, TN, DCI employs more than 5,000 people serving approximately 15,000 dialysis patients. DCI's services include in-center hemodialysis, in-center self-care hemodialysis, home hemodialysis, continuous ambulatory peritoneal dialysis (CAPD), continuous cycling peritoneal dialysis (CCPD) and Hospital Services (inpatient renal replacement therapy). For more information, visit www.dciinc.org.
"It is an accomplishment for the many patients who joined the study and for the clinical staff at DCI units to have undertaken a trial of this size and this scope and answered an important question. While it is disappointing that oral protein supplements, items like protein bars that you can buy at any store, did not lower mortality in hemodialysis patients with good nutritional status, it is important to say that this result does not tell us anything about giving protein supplements to people with low serum albumin. We do have observational data that suggest protein supplements have benefits in dialysis patients with low albumin," said Daniel Weiner, MD, of Tufts Medical Center in Boston and Medical Director of Clinical Research for DCI.
More on AkGlobe News
- The UK's Leading Digital Marketing Agency, Finsbury Media Announces Employees Will Be Allowed To Work From Home:
- NMEA 2000 Development and Prototyping Boards for Marine Applications
- ICTBroadast Version 4.1, Advance call center software for your needs
- Alaska: Governor Dunleavy Appoints Ed Sniffen to Attorney General
- Alaska: Governor Dunleavy Recognizes Martin Luther King Jr. Day
The cluster randomized pragmatic study, named The HELPS-HD Trial, enrolled 10,457 patients from 105 DCI participating facilities. Patients were randomized to either the standard protocol group, whereby only those patients with an albumin level below 3.5 g/dL received supplement, or the intensive protocol group, where supplements were given to patients regardless of their albumin levels. The most common supplements used were protein bars, and all supplements had approximately 15g to 20g of protein. Mean follow-up was 21.2 months.
"We tried to keep this as real-world and pragmatic as possible," Weiner said.
At the conclusion of the study, there were 3,628 deaths, with 35.8% from the intensive group and 36.5% from the standard group. There was no significant difference in the death rate between the groups, even after adjusting for age, sex, race, and incident patient status.
"To be able to verbally consent over 10,000 patients in a randomized clinical trial is a testament to the dedication of the DCI staff to our patients and to our mission as a company. I am very proud to work for DCI and this incredible team in our quest to find the best possible care for our patients," said Karen Majchrzak, Director of Clinical Research at DCI.
More on AkGlobe News
- Alaska: Martin Luther King, Jr. Day
- CEO of Industrial Giant ABB in Brazil Joins CEO Coaching International
- Fighting Pest Problems with The Safest Pest Control Dubai Residents Can Get
- Best Advertising Methods To Attract People To Your Events Post COVID-19 by Duluth Businessman Ismail Sirdah
- Thirteen MBK Senior Living Communities Receive "2021 Best of Senior Living" Distinction
About DCI
Founded in 1971, Dialysis Clinic, Inc. (DCI) is the nation's largest non-profit dialysis provider with over 250 dialysis clinics in 30 states. Headquartered in Nashville, TN, DCI employs more than 5,000 people serving approximately 15,000 dialysis patients. DCI's services include in-center hemodialysis, in-center self-care hemodialysis, home hemodialysis, continuous ambulatory peritoneal dialysis (CAPD), continuous cycling peritoneal dialysis (CCPD) and Hospital Services (inpatient renal replacement therapy). For more information, visit www.dciinc.org.
Source: Dialysis Clinic Inc. (DCI)
0 Comments
Latest on AkGlobe News
- Juneau: Increased avalanche risk along Thane Road
- Texpak Offers Environmentally-Friendly Ecotach™ Fasteners to Address Sustainability Needs
- Morningstar names Quantified STF Fund top-performing tactical-allocation fund in 2020
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Juneau: How to get on the wait list for Jan. 15-17 vaccine clinic
- CBJ reports two new COVID-19 cases in Juneau
- Juneau: Update on COVID-19 Individual Assistance & Housing Assistance programs
- Juneau's 14-day COVID-19 recap: Dec. 28 – Jan. 10
- SHELTER, New Works by Artists Byron Keith Byrd, Stefani Byrd, and Fenix Gallery Collective, January 20–February 24, 2021
- AI.Reverie Awarded $950 Million IDIQ Contract for U.S. Air Force Advanced Battle Management System (ABMS)
- Updated ASI Book Helps Association Executives Improve Organizational Performance Now and Post-COVID
- CBJ reports one new COVID-19 case in Juneau
- MBK Senior Living Ranks 7th On Fortune Best Workplaces For Aging Services List
- Juneau Libraries, City Museum & Permit Center return to in-person service; pools & ice rink adjust operations
- Alaska: Dunleavy Administration Reopens Two Interior Road Maintenance Stations
- Fifth Gen Media announces Darlene Pope as Chairman of the Advisory Council
- Phinge To Launch Netverse, a Rewards-Based Alternative to Apple and Google Using Innovative Proprietary Technology and Patented Mobile Devices
- Spivey Hall Children's Choir Looks To 2021 Through The Lens of Langston Hughes Poetry
- Wohler releases AoIP & Analog options for their iVAM1-1
- While Supplies Last: Thermal Transfer Label Sale